Royalty Report: Drugs, Alzheimer’s disease, Drug Discovery – Collection: 315528

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 8

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 8

Primary Industries

  • Drugs
  • Alzheimer’s disease
  • Drug Discovery
  • Disease

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 315528

License Grant
Licensor (a nonstock, nonprofit Florida corporation, and a direct support organization of the University of South Florida) grants to Licensee a) an exclusive license, limited to the Licensed Field and the Licensed Territory, under the Licensed Patents to make, have made, develop, use, lease, import, export, offer to sell, sell and have sold Licensed Products and/or Licensed Processes, and a non-exclusive license, limited to the Licensed Field and the Licensed Territory, under the Know-How to make, have made, develop, use, lease, import, export, offer to sell, sell and have sold Licensed Products and/or Licensed Processes. Licensor reserves to itself, University, and to all nonprofit entities with which it collaborates the right under the Licensed Patents to make, have made, develop, import and use Licensed Products and Licensed Processes solely for their internal research, clinical and educational purposes.
License Property
The patent is Organic Anion Lithium Ionic Cocrystal Compounds and Compositions.
Field of Use
Licensed Field means the field of LiProSal (lithium co-crystal) for the treatment of Neurodegenerative Diseases excluding Alzheimer’s Disease.

Licensee was formed to acquire and commercialize patented intellectual property and know how to prevent, treat and cure Alzheimer’s disease.

IPSCIO Record ID: 315527

License Grant
Licensor (a nonstock, nonprofit Florida corporation, and a direct support organization of the University of South Florida) grants to Licensee a) an exclusive license, limited to the Licensed Field and the Licensed Territory, under the Licensed Patents to make, have made, develop, use, lease, import, export, offer to sell, sell and have sold Licensed Products and/or Licensed Processes, and a non-exclusive license, limited to the Licensed Field and the Licensed Territory, under the Know-How to make, have made, develop, use, lease, import, export, offer to sell, sell and have sold Licensed Products and/or Licensed Processes. Licensor reserves to itself, University, and to all nonprofit entities with which it collaborates the right under the Licensed Patents to make, have made, develop, import and use Licensed Products and Licensed Processes solely for their internal research, clinical and educational purposes.
License Property
The patent is Organic Anion Lithium Ionic Cocrystal Compounds and Compositions.
Field of Use
Licensed Field means the field of LiProSal (lithium co-crystal) for the treatment of Psychiatric Diseases/Disorders.

IPSCIO Record ID: 259986

License Grant
The University hereby grants to Licensee an exclusive license, limited to the Licensed Field and the Licensed Territory, under the Licensed Patents to make, have made, develop, use, lease, import, export, offer to sell, sell and have sold Licensed Products and/or Licensed Processes, and a royalty bearing, non-exclusive license, limited to the Licensed Field and the Licensed Territory, under the Know-How to make, have made, develop, use, lease, import, export, offer to sell, sell and have sold Licensed Products and/or Licensed Processes.  Licensee may grant written Sublicenses.
License Property
The patent, products and processes relate to Organic Anion Lithium Ionic Cocrystal Compounds and Compositions.
Field of Use
The Licensed Field shall be limited to the use of LiSPro for the treatment of Alzheimer’s Disease.
LiProSalTM is an ionic cocrystal of lithium for the treatment of Alzheimer’s and possibly other neurodegenerative diseases. Recent evidence suggests that lithium may be efficacious for both the treatment and prevention of AD.

IPSCIO Record ID: 259987

License Grant
The University hereby grants to Licensee a) a royalty-bearing, exclusive license, limited to the Licensed Field and the Licensed Territory, under the Licensed Patents to make, have made, develop, use, lease, import, export, offer to sell, sell and have sold Licensed Products and/or Licensed Processes, and b) a royalty bearing, non-exclusive license, limited to the Licensed Field and the Licensed Territory, under the Know-How to make, have made, develop, use, lease, import, export, offer to sell, sell and have sold Licensed Products and/or Licensed Processes.
License Property
Lithium Co-Crystals for Treatment of Neuropsychiatric Disorders.
Field of Use
The Licensed Field shall be limited to the use of LiSPro for the treatment of Alzheimer’s Disease.

IPSCIO Record ID: 362501

License Grant
For the Option. Licensor grants to the Licensee of England an irrevocable option, to be exercised at Licensees sole discretion, to acquire the license described.

For the Grant of License. when Licensee exercises the option, Licensor grants, commencing immediately upon exercise of the Option and for the term of this Agreement, a non-exclusive, license under the Licensed Patents, with the right to grant sublicenses, to develop, have developed, make, have made, use, offer to sell, sell, import and have imported Licensed Products in the Territory in the Field.

License Property
Licensor is the owner of the Licensed Patents for DNA Encoding Recombinant Antibody Molecules End Specific For Amyloid B Peptides, and, Pharmaceutical Preparations Thereof and Method of Preventing or Inhibiting Progression of Alzheimers Disease.

Licensees Compound means any compound, including but not limited to an antibody directed towards Beta Amyloid.

Licensed Product means any product in any dosage form, the development, manufacture, use, sale or importation of which product would, absent the grant by Licensor to Licensee of the license described herein, infringe any Valid Claim in any Licensed Patent. To avoid any doubt, Licensed Product shall include, without limitation, the Licensees Antibody currently under development for treatment of Alzheimers disease, designated x-933776A

Field of Use
Field means the treatment, prevention and/or control of all diseases and/or conditions in humans, including but not limited to Alzheimers and Mild Cognitive Impairment.

IPSCIO Record ID: 362534

License Grant
For the Option, Licensor grants an irrevocable option, to be exercised at Licensee’s sole unfettered discretion, to acquire the license described.  The Option may be exercised any time from the Effective Date until March 31, 2009.

For the Grant of License, Licensor grants, commencing immediately upon exercise of the Option and for the term of this Agreement, a non-exclusive license under the Licensed Patents, with the right to grant sublicenses, to develop, have developed, make, have made, use, offer to sell, sell, import and have imported Licensed Products in the Territory in the Field.

License Property
Licensor is the owner of the Licensed Patents for DNA Encoding Recombinant Antibody Molecules End-Specific For Amyloid – B  Peptides, and, Pharmaceutical Compositions Thereof and Method of Preventing or Inhibiting Progression of Alzheimers Disease.

Lead Compound means Licensees antibody directed toward Amyloid Beta, commonly referred to within Licensee xx-04360365

Licensed Product means any product in any dosage form containing the licensed Pfizer Compound, the development, manufacture, use, sale or importation of which product would, absent the license granted by Licensor to Licensee herein, infringe any Valid Claim in any Licensed Patent.

Pfizer Compound means any antibody owned or licensed by Licensee or an Affiliate directed towards Amyloid Beta, including the Lead Compound.

Field of Use
The Field shall mean the treatment, prevention and/or control of all diseases and/or conditions in humans, including but not limited to Alzheimer’s Disease and Mild Cognitive Impairment.

IPSCIO Record ID: 291175

License Grant
University hereby grants to Israel Corporation and Corporation hereby accepts from University the License. License shall mean the exclusive worldwide license to practice University’s share in the University Research Technology (as hereinafter defined) for the development, manufacture, use and sale of the Licensed Products (as hereinafter defined). At the initiative of Corporation or University, the parties shall consult with each other regarding the prosecution of all patent applications with respect to the University Research Technology. University and Corporation shall assist, and cause their respective employees and consultants to assist, each other in assembling inventorship information and data for the filing and prosecution of patent applications on inventions pertaining to the Research Technology. Corporation shall be entitled to grant sublicenses under the License on terms and conditions in compliance and not inconsistent with the terms and conditions of this Agreement (except that the rate of royalty may be at higher rates than those set forth in this Agreement) (i) to a Corporation Entity or (ii) to other third parties for consideration and in an arms-length transaction.
License Property
Licensed Products shall mean all products, drugs, diagnostic reagents, diagnostic methods, therapeutic agents and therapeutic methods covered by a claim of any unexpired University Patents (as hereinafter defined) which has not been disclaimed or held invalid by a court of competent jurisdiction from which no appeal has been or can be taken.

University Research Technology shall mean all University Patents and all University Know-How.

University Patents shall mean all United States and foreign patents and patent applications, and any divisions, continuations, in whole or in part, reissues, renewals and extensions thereof, and pending applications therefor
(1)  
which claim Pre-Existing Inventions and which are identified hereto; or
(2)  
which claim inventions that are made, in whole or in part, by students or employees of SAMSF during the term and in the course of the Research Project;  
with the exception of all such patents which are Corporation Patents as hereinafter defined.
U.S. Patent Application Serial No. 08/801,301, filed February 18, 1997 entitled Use if Nekatibub To Prevent Cytotoxic effects of Amyloid Protein by Pappolla.
U.S. Provisional Patent Application Serial No. 60/075,555 filed February 23, 1998 entitled Use of 3-Indol-Proprionic acid by Pappolla
U.S. Provisional Patent Application Serial No. 60/079,349 filed March 25, 1998 entitled Inhibition of Alzheimer of Alzheimer Beta-Fibrillogenesis by Mela Tonm by Pappolla.

Corporation Patents shall mean all United States and foreign patents and patent applications, and any divisions, continuations, in whole or in part, reissues, renewals and extensions thereof, and pending applications therefor which claim inventions that are made, in whole or in part, by students or employees of Corporation.

Research Technology shall mean all University Patents, University Know-How, Corporation Patents and Corporation Know-How.

Field of Use
Field shall mean research, development and testing within pharmaceutical, biotechnological and diagnostic development programs in the field of Alzheimer’s Disease and other central nervous system and neurodegenerative diseases, and in the field of all other possible utilities for melatonin analogs.

IPSCIO Record ID: 369341

License Grant
University hereby grants to Licensee the right and license to make, have made, use, import, lease and sell the Licensed Products and Licensed Processes and Know-How throughout the world in any and all fields of use to the end of the term for which the Patent Rights are granted unless sooner terminated according to the terms hereof, subject to the non­exclusive licenses granted to the United States Government.

In order to establish exclusivity for Licensee, University hereby agrees that it shall not grant any other license to make, have made, use, import, lease and sell Licensed Products or to utilize Licensed Processes throughout the world in any or all fields of use during the period of time commencing with the Effective Date of this Agreement and terminating with the expiration of this Agreement.

University hereby grants to Licensee an exclusive option to negotiate for an exclusive license to sublicense, manufacture, use and sell products and processes based on or under University Inventions, University Patents and the University’s component of Joint Inventions arising under Project Work as described and defined in this Agreement.

License Property
Patent relates to a method of protection against cell loss using polycyclic phenols, including estrogens.

U.S. Patent 5,554,601 – Methods for neuroprotection

Field of Use
Field of use is for treating neurodegenerative diseases including Alzheimers disease through the use of estrogens.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.